REBECCA STAMPER: Open Payments
NPI 1225637275 · MOREHEAD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$869 in 43 payments from 9 companies in 2025. Trend: 2023 $659 · 2024 $1,016 · 2025 $869
Food & beverage: $869
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $309 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 15 | $197 |
| Kestra Medical Technology Services, Inc. | 2 | $107 |
| Novo Nordisk Inc | 3 | $76 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| AtriCure, Inc. | 2 | $35 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: LEQVIO, LifeVest, Assure WCD, Wegovy, BRILINTA, ATRICLIP LAA EXCLUSION SYSTEM, VERQUVO, CAMZYOS.
Industry payments across KY — which companies pay providers there.
